-
Takao
Watanabe,
Mitsutoshi
Nakamura,
J.
Kros,
C.
Burkhard,
Y.
Yonekawa,
P.
Kleihues,
H.
Ohgaki
(2002)
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas
Acta Neuropathologica, 103
-
C.
Hartmann,
Jochen
Meyer,
Jörg
Balss,
D.
Capper,
W.
Mueller,
Arne
Christians,
J.
Felsberg,
M.
Wolter,
C.
Mawrin,
W.
Wick,
M.
Weller,
C.
Herold‐Mende,
A.
Unterberg,
J.
Jeuken,
P.
Wesseling,
G.
Reifenberger,
A.
Deimling
(2009)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Acta Neuropathologica, 118
-
H.
Dubbink,
W.
Taal,
R.
Marion,
J.
Kros,
I.
Heuvel,
J.
Bromberg,
B.
Zonnenberg,
C.
Zonnenberg,
T.
Postma,
J.
Gijtenbeek,
W.
Boogerd,
F.
Groenendijk,
F.
Groenendijk,
P.
Smitt,
W.
Dinjens,
M.
Bent
(2009)
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
Neurology, 73
-
J.
Kros,
T.
Gorlia,
M.
Kouwenhoven,
P.
Zheng,
V.
Collins,
D.
Figarella-Branger,
F.
Giangaspero,
C.
Giannini,
K.
Mokhtari,
S.
Mørk,
A.
Paetau,
G.
Reifenberger,
M.
Bent
(2007)
Panel Review of Anaplastic Oligodendroglioma From European Organization for Research and Treatment of Cancer Trial 26951: Assessment of Consensus in Diagnosis, Influence of 1p/19q Loss, and Correlations With Outcome
Journal of Neuropathology and Experimental Neurology, 66
-
D.
Maintz,
K.
Fiedler,
J.
Koopmann,
B.
Rollbrocker,
Stefan
Nechev,
A.
Stangl,
D.
Louis,
J.
Schramm,
O.
Wiestler,
A.
Deimling
(1997)
Molecular Genetic Evidence for Subtypes of Oligoastrocytomas
Journal of Neuropathology and Experimental Neurology, 56
-
Takuya
Watanabe,
S.
Nobusawa,
P.
Kleihues,
H.
Ohgaki
(2009)
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
The American journal of pathology, 174 4
-
L.
Gravendeel,
Nanne
Kloosterhof,
L.
Bralten,
R.
Marion,
H.
Dubbink,
W.
Dinjens,
F.
Bleeker,
C.
Hoogenraad,
E.
Michiels,
J.
Kros,
M.
Bent,
P.
Smitt,
P.
French
(2010)
Segregation of non‐p.R132H mutations in IDH1 in distinct molecular subtypes of glioma
Human Mutation, 31
-
S.
Nobusawa,
Takuya
Watanabe,
P.
Kleihues,
H.
Ohgaki
(2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Clinical Cancer Research, 15
-
Hai
Yan,
D.
Parsons,
Geng-lin
Jin,
R.
McLendon,
B.
Rasheed,
Weishi
Yuan,
I.
Kos,
I.
Batinic-Haberle,
Siân
Jones,
G.
Riggins,
H.
Friedman,
A.
Friedman,
D.
Reardon,
J.
Herndon,
Kenneth
Kinzler,
V.
Velculescu,
B.
Vogelstein,
D.
Bigner
(2009)
IDH1 and IDH2 mutations in gliomas.
The New England journal of medicine, 360 8
-
S.
Kesari,
D.
Schiff,
J.
Drappatz,
D.
Lafrankie,
L.
Doherty,
E.
Macklin,
A.
Muzikansky,
S.
Santagata,
K.
Ligon,
A.
Norden,
A.
Ciampa,
J.
Bradshaw,
B.
Levy,
Gospova
Radakovic,
N.
Ramakrishna,
P.
Black,
P.
Wen
(2008)
Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
Clinical Cancer Research, 15
-
H.
Ohgaki,
Pierre
Dessen,
B.
Jourde,
Sonja
Horstmann,
Tomofumi
Nishikawa,
P.
Patre,
C.
Burkhard,
D.
Schüler,
N.
Probst-Hensch,
P.
Maiorka,
N.
Baeza,
P.
Pisani,
Y.
Yonekawa,
M.
Yasargil,
U.
Lütolf,
P.
Kleihues
(2004)
Genetic Pathways to Glioblastoma
Cancer Research, 64
-
D.
Louis
(2007)
WHO classification of tumours of the central nervous system
-
A.
Korshunov,
Jochen
Meyer,
D.
Capper,
Arne
Christians,
M.
Remke,
H.
Witt,
S.
Pfister,
A.
Deimling,
C.
Hartmann
(2009)
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
Acta Neuropathologica, 118
-
S.
Coons,
P.
Johnson,
B.
Scheithauer,
A.
Yates,
D.
Pearl
(1997)
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas
Cancer, 79
-
Takao
Watanabe,
Y.
Katayama,
A.
Yoshino,
C.
Komine,
Takakazu
Yokoyama
(2003)
Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 13
-
Yoshikazu
Okamoto,
P.
Patre,
C.
Burkhard,
Sonja
Horstmann,
B.
Jourde,
M.
Fahey,
D.
Schüler,
N.
Probst-Hensch,
M.
Yașargil,
Y.
Yonekawa,
U.
Lütolf,
P.
Kleihues,
H.
Ohgaki
(2004)
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas
Acta Neuropathologica, 108
-
G.
Reifenberger,
D.
Louis
(2003)
Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro‐Oncology
JNEN: Journal of Neuropathology & Experimental Neurology, 62
-
J.
Nigro,
M.
Takahashi,
D.
Ginzinger,
M.
Law,
S.
Passe,
Robert
Jenkins,
K.
Aldape
(2001)
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
The American journal of pathology, 158 4
-
M.
Bent,
H.
Dubbink,
Y.
Marie,
A.
Brandes,
M.
Taphoorn,
P.
Wesseling,
M.
Frénay,
C.
Tijssen,
D.
Lacombe,
A.
Idbaih,
R.
Marion,
J.
Kros,
W.
Dinjens,
T.
Gorlia,
M.
Sanson
(2010)
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Clinical Cancer Research, 16
-
H.
Ohgaki,
P.
Kleihues
(2005)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Journal of neuropathology and experimental neurology, 64 6
-
N.
Ishii,
M.
Tada,
M.
Hamou,
R.
Janzer,
K.
Meagher‐Villemure,
O.
Wiestler,
N.
Tribolet,
Erwin
Meir
(1999)
Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor
Oncogene, 18
-
K.
Ichimura,
D.
Pearson,
S.
Kocialkowski,
L.
Bäcklund,
R.
Chan,
David
Jones,
V.
Collins
(2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Neuro-oncology, 11 4
-
MD
Kaloshi,
A.
Benouaich-Amiel,
MD
Diakite,
MD
Taillibert,
MSc
Lejeune,
MD
Laigle-Donadey,
MSc
Renard,
W.
Iraqi,
MD
Idbaih,
MSc
Paris,
MD
Capelle,
MD
Duffau,
MD
Cornu,
MD
Simon,
MD
Mokhtari,
MD
Polivka,
MD
Omuro,
MD
Carpentier,
MD
Sanson,
MD
Delattre,
M.
Hoang-Xuan,
Dr.
Hoang-Xuan,
Service
de,
Neurologie
Mazarin,
Groupe
Hospitalier
(2007)
Temozolomide for low-grade gliomas
Neurology, 68
-
M.
Sanson,
Y.
Marie,
S.
Paris,
A.
Idbaih,
J.
Laffaire,
F.
Ducray,
S.
Hallani,
B.
Boisselier,
K.
Mokhtari,
K.
Hoang-Xuan,
J.
Delattre
(2009)
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 25
-
W.
Mueller,
C.
Hartmann,
A.
Hoffmann,
W.
Lanksch,
J.
Kiwit,
J.
Tonn,
J.
Veelken,
J.
Schramm,
M.
Weller,
O.
Wiestler,
D.
Louis,
A.
Deimling
(2002)
Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.
The American journal of pathology, 161 1
-
C.
Fuller,
R.
Schmidt,
K.
Roth,
P.
Burger,
B.
Scheithauer,
Ruma
Banerjee,
K.
Trinkaus,
R.
Lytle,
A.
Perry
(2003)
Clinical Utility of Fluorescence In Situ Hybridization (FISH) in Morphologically Ambiguous Gliomas with Hybrid Oligodendroglial/Astrocytic Features
JNEN: Journal of Neuropathology & Experimental Neurology, 62
-
A.
Peraud,
F.
Kreth,
O.
Wiestler,
P.
Kleihues,
H.
Reulen
(2002)
Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Clinical cancer research : an official journal of the American Association for Cancer Research, 8 5
-
Kunihiko
Watanabe,
O.
Tachibana,
Kazufumi
Sato,
Y.
Yonekawa,
P.
Kleihues,
H.
Ohgaki
(1996)
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
Brain Pathology, 6
-
D.
Louis,
H.
Ohgaki,
O.
Wiestler,
W.
Cavenee,
P.
Burger,
A.
Jouvet,
B.
Scheithauer,
P.
Kleihues
(2007)
The 2007 WHO Classification of Tumours of the Central Nervous System
Acta Neuropathologica, 114
-
R.
Jenkins,
H.
Blair,
K.
Ballman,
C.
Giannini,
R.
Arusell,
M.
Law,
H.
Flynn,
S.
Passe,
Sara
Felten,
P.
Brown,
E.
Shaw,
J.
Buckner
(2006)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Cancer research, 66 20
-
Jörg
Balss,
Jochen
Meyer,
W.
Mueller,
A.
Korshunov,
C.
Hartmann,
A.
Deimling
(2008)
Analysis of the IDH1 codon 132 mutation in brain tumors
Acta Neuropathologica, 116